According to CapBio's announcement, in December 2025, the company and its subsidiaries obtained patent authorization for the invention of “a paper-based gene chip sampling method, device, storage medium and equipment”. The patent number is 202510709179.6. The patentees are Capcom Biotech, Guangdong Cape Technology Intelligent Manufacturing Co., Ltd., and Hanshan Normal University. The invention uses AI technology to dynamically adjust sampling parameters according to chip characteristics, which can improve sampling quality and work efficiency. The patent acquisition is in line with the company's strategic plan. Although it will not have a significant impact on the current business situation, it is conducive to improving the intellectual property system and enhancing core competitiveness.

According to CapBio's announcement, in December 2025, the company and its subsidiaries obtained patent authorization for the invention of “a paper-based gene chip sampling method, device, storage medium and equipment”. The patent number is 202510709179.6. The patentees are Capcom Biotech, Guangdong Cape Technology Intelligent Manufacturing Co., Ltd., and Hanshan Normal University. The invention uses AI technology to dynamically adjust sampling parameters according to chip characteristics, which can improve sampling quality and work efficiency. The patent acquisition is in line with the company's strategic plan. Although it will not have a significant impact on the current business situation, it is conducive to improving the intellectual property system and enhancing core competitiveness.